Prevymis (letermovir) - Merck (MSD)
https://eacs2025.abstractserver.com/program/#/details/presentations/441
 
S. Isnard 1,2; L. Royston 1,3; C.A Berini 1,2; T. Mabanga 1,2; J. Girouard 1,2; T. Bessissow 4; P.L Lakatos 4,5; C.T Costiniuk 1,2; B. Lebouché 1,2; J.-P. Routy 1,2,6; CTN PT047 CIAO study
 
Jul 16, 2025
 
Prev Next